MR. KANG SPECIALIZES IN REGULATORY COMPLIANCE, ADMINISTRATIVE LAW AND NATIONAL SECURITY REVIEW. HE HAS EXTENSIVE EXPERIENCE IN HANDLING VARIOUS COMPLIANCE MATTERS FOR COMPANIES, RESPONDING TO ADMINISTRATIVE INVESTIGATIONS, ADMINISTRATIVE RECONSIDERATIONS, LITIGATIONS, AND CRISIS MANAGEMENT.
Mr. Kang’s practice areas include advertising, anti-unfair competition, EHS, securities and finance, export control and sanctions, among others. He has long been involved in handling various legal compliance matters for multinational and domestic enterprises across multiple industries. Mr. Kang also has extensive experience in identifying compliance risks and building compliance systems.
Mr. Kang is skilled in handling administrative disputes and has represented clients in numerous administrative investigations, administrative reconsiderations, administrative litigations, and crisis response cases. He is well-versed in the trial procedures, judicial thinking, and working methods of administrative agencies and courts, and is able to propose constructive and actionable dispute resolution based on specific case circumstances.
Mr. Kang has extensive experience in foreign investment national security review and has handled numerous national security review risk assessments, consultations and notifications in different industries.

MR. LEI YANG’S KEY PRACTICE AREAS ARE CORPORATE COMPLIANCE, INTERNAL INVESTIGATION, AND GOVERNMENT ENFORCEMENT (INCLUDING MDB SANCTION MATTERS). Mr. Yang has more than a decade of experience as a lawyer. Having experiences in compliance and dispute resolution practice in both the PRC and the U.S. has enabled him to be especially good at representing clients in solving complicated cross-border regulatory compliance, government enforcement, and dispute resolution matters.
Mr. Yang has represented clients in a wide range of areas, such as anti-bribery, anti-unfair competition, fraud, conflict of interest, trade secret protection, multilateral bank sanctions, ESG and supply chain compliance, etc.

Dr. Wang has extensive experience in the field of criminal litigation and investigation, he mainly practices in criminal defense, criminal case filing, company compliance, administrative law enforcement and internal anti-fraud investigation. Prior to joining Fangda, Dr. Wang worked in Criminal Court, Beijing No.4 Intermediate People's Court for 12 years, in his capacity of Judge Assistant and Judge consecutively. He had rich experience in handling cases involving corruption, bribery, civil rights protection, drugs smuggling. Dr. Wang presided over grave and complicated cases for many times, one of the cases he heard was enlisted in Criminal Guidance Cases by the Supreme People's Court. Dr. Wang participated in the research and revision of the crime of securities fraud in the Eighth Amendment to the Criminal Law. His professional thesis and articles had been published in the top journals of law profession many times. Dr. Wang was awarded the honorary title of Beijing Model Judge by Beijing Higher People's Court in 2014.

As a U.S.-trained attorney who has worked in China for over a decade, Calvin leverages his international background and local expertise to advise clients in navigating their most pressing and challenging regulatory, compliance, internal and government investigations, litigation and dispute resolution matters.
In the investigations space, Calvin has represented companies and their board committees in matters ranging from corruption and conflicts of interest, to trade compliance and cybersecurity incidents. These investigations span industries, and include work for market leaders in the life sciences, technology and telecommunications, chemicals, automotive, diversified industrials and retail sectors.
To help clients avoid problems, Calvin regularly advises on the design and implementation of comprehensive anti-corruption compliance programs, as well as providing guidance on pre-acquisition due diligence, risk assessments, and remediation. Having spent several years working on the day-to-day implementation of an FCPA compliance program in China to address what was then the largest FCPA case brought by the U.S. Government, Calvin has developed a keen understanding and anticipation for the ways the U.S. Government evaluates official corruption issues and the steps a company takes to forestall and address such problems. In addition, Calvin has served as a member of the anti-corruption compliance monitor team for a global medical device company during a 3-year resolution related to a World Bank Group investigation.